Liu, Bo, Granville, David J., Golledge, Jonathan, and Kassiri, Zamaneh (2020) Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm. American Journal of Physiology-Heart and Circulatory Physiology, 318 (3). H652-H670.

PDF (Published Version) - Published Version Restricted to Repository staff only

 

22

1

Abstract

Aortic aneurysm is a permanent focal dilation of the aorta. It is usually an asymptomatic disease but can lead to sudden death due to aortic rupture. Aortic aneurysm-related mortalities are estimated at similar to 200,000 deaths per year worldwide. Because no pharmacological treatment has been found to be effective so far, surgical repair remains the only treatment for aortic aneurysm. Aortic aneurysm results from changes in the aortic wall structure due to loss of smooth muscle cells and degradation of the extracellular matrix and can form in different regions of the aorta. Research over the past decade has identified novel contributors to aneurysm formation and progression. The present review provides an overview of cellular and noncellular factors as well as enzymes that process extracellular matrix and regulate cellular functions (e.g., matrix metalloproteinases, granzymes, and cathepsins) in the context of aneurysm pathogenesis. An update of clinical trials focusing on therapeutic strategies to slow abdominal aortic aneurysm growth and efforts underway to develop effective pharmacological treatments is also provided.

Actions (Repository Staff Only)

Item Control Page